期刊文献+

Application of Benchmark Dose (BMD) in Estimating Biological Exposure Limit (BEL) to Cadmium 被引量:3

Application of Benchmark Dose (BMD) in Estimating Biological Exposure Limit (BEL) to Cadmium
下载PDF
导出
摘要 Objective To estimate the biological exposure limit (BEL) using benchmark dose (BMD) based on two sets of data from occupational epidemiology. Methods Cadmium-exposed workers were selected from a cadmium smelting factory and a zinc product factory. Doctors, nurses or shop assistants living in the same area served as a control group. Urinary cadmium (UCd) was used as an exposure biomarker and urinary D2-microgloburin (B2M), N-acetyl-D-D-glucosaminidase (NAG) and albumin (ALB) as effect biomarkers. All urine parameters were adjusted by urinary creatinine. Software of BMDS (Version 1.3.2, EPA.U.S.A) was used to calculate BMD. Results The cut-off point (abnormal values) was determined based on the upper limit of 95% of effect biomarkers in control group. There was a significant dose response relationship between the effect biomarkers (urinary B2M, NAG9 and ALB) and exposure biomarker (UCd). BEL value was 5 μg/g creatinine for UB2M as an effect biomarker, consistent with the recommendation of WHO. BEL could be estimated by using the method of BMD. BEL value was 3 μg/g creafinine for UNAG as an effect biomarker. The more sensitive the used biomarker is, the more occupational population will be protected. Conclusion BMD can be used in estimating the biological exposure limit (BEL). UNAG is a sensitive biomarker for estimating BEL after cadmium exposure. Objective To estimate the biological exposure limit (BEL) using benchmark dose (BMD) based on two sets of data from occupational epidemiology. Methods Cadmium-exposed workers were selected from a cadmium smelting factory and a zinc product factory. Doctors, nurses or shop assistants living in the same area served as a control group. Urinary cadmium (UCd) was used as an exposure biomarker and urinary D2-microgloburin (B2M), N-acetyl-D-D-glucosaminidase (NAG) and albumin (ALB) as effect biomarkers. All urine parameters were adjusted by urinary creatinine. Software of BMDS (Version 1.3.2, EPA.U.S.A) was used to calculate BMD. Results The cut-off point (abnormal values) was determined based on the upper limit of 95% of effect biomarkers in control group. There was a significant dose response relationship between the effect biomarkers (urinary B2M, NAG9 and ALB) and exposure biomarker (UCd). BEL value was 5 μg/g creatinine for UB2M as an effect biomarker, consistent with the recommendation of WHO. BEL could be estimated by using the method of BMD. BEL value was 3 μg/g creafinine for UNAG as an effect biomarker. The more sensitive the used biomarker is, the more occupational population will be protected. Conclusion BMD can be used in estimating the biological exposure limit (BEL). UNAG is a sensitive biomarker for estimating BEL after cadmium exposure.
出处 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2007年第6期460-464,共5页 生物医学与环境科学(英文版)
关键词 Benchmark dose Biological exposure limit BIOMARKER Benchmark dose Biological exposure limit Biomarker
  • 相关文献

参考文献14

  • 1Crump K S (1984). A new method for determining allowable daily intakes. FundamAppl Toxicol 4, 854-871.
  • 2Gaylor D, Ryan L, Krewski D, et al. (1998). Procedures for calculating benchmark doses for health risk assessment. Regul Toxicol Pharmaco128, 150-164.
  • 3Kobayashi E, Suwazono Y, Uetani M, et al. (2006). Estimation of benchmark dose as the threshold levels of urinary cadmium based on excretion of total protein, beta (2)-microglobulin, and N-acetyl-beta-d-glucosaminidase in cadmium nonpolluted regions in Japan. Environ Res 101,401-406,
  • 4Jarup L, Berglund M, Elinder C G, et al. (1998). Health effects of cadmium exposure-A review of the literature and a risk estimate. Scand Work Environ Health 24, 1-51.
  • 5Buchet J P, Lauwerys R R, Roles H (1990). Renal effects of cadmium body burden of the general population. Lancet 336, 699-702.
  • 6American Conference of Governmental Industrial Hygienists (2004). Biological exposure indices adopted by ACGIH with intended chanees for 2004. USA, ACGIH.
  • 7The People's Republic of China (1999). Health standard for biological monitoring indices and occupational exposure limit (WSIT113-199), Beijing. (in Chinese).
  • 8Tucker S M, Boye P J, Thompso A E (1975). Automated assay of N-acetyl-13-D-glucosaminidase in normal and pathological human urine. ChimActa 62, 333-339.
  • 9Hare R S (1950). Endogenous creatinine serum and urine, Proc Soc Exp Biol Med 74, 148-151.
  • 10Jin T, Nordberg M, Frech W (2002). Cadmium biomonitoring and renal dysfunction among a population environmentally exposed to cadmium from smelting in China. Biometals 15, 397-410.

同被引文献9

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部